Warner Pharmaceuticals (688799.SH): Metaxolamine bitartrate injection obtained drug registration certificate

Zhitongcaijing · 6d ago

Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) announced that the company received the “Drug Registration Certificate” for metoxylamine bitartrate injections approved and issued by the State Drug Administration. Metaxylamine bitartrate injections are suitable for preventing acute hypotension during intraponeal block anesthesia; low blood pressure caused by bleeding, drug allergies, surgical complications, and traumatic brain injury or brain tumor combined with shock; this product can also be used for adjuvant symptomatic treatment of septic symptoms; it can also be used for hypotension caused by cardiogenic shock or hememia.